90-Second Read: Ebola surge, CDC Hantavirus data spur demand for hospital-grade cleaning

TOMI Environmental Solutions (NASDAQ:TOMZ) highlights expanded market opportunity for its SteraMist decontamination platform amid a WHO-flagged Ebola outbreak in Central Africa and CDC-published Hantavirus research. Today's CDC-linked Hantavirus and Ebola context continues this outbreak-driven commercial positioning theme. WHO-flagged Ebola outbreak and rising Hantavirus exposure risks underscore growing institutional demand for scalable, hospital-grade decontamination solutions across healthcare, hospitality, transportation, and agricultural infrastructure. Nearly 30% of rodents in a new study carried Hantavirus markers, elevating risks for farms and factories as TOMI promotes SteraMist decontamination tech.

News on May 7 highlighting Hantavirus remediation coincided with a 16.22% move, while Ebola-focused updates on May 22 and May 19 saw gains of 5.98% and 4.37%. SNV is the primary causative agent of Hantavirus Pulmonary Syndrome (HPS) in the United States, a severe respiratory disease with a high fatality rate. Hantavirus is transmitted to humans primarily through the inhalation of aerosolized rodent excreta, including urine, droppings, or saliva. TOMZ is up 12.39% while momentum peers like LIQT ( -19.9% ) and SCWO ( -5.8% ) are down, indicating a stock-specific reaction to outbreak-focused news rather than a broad sector move.

This announcement ties TOMI's SteraMist platform to CDC-published data showing nearly 30% rodent exposure and about 10% active Sin Nombre virus infections, alongside WHO-flagged Ebola risks. Against a backdrop of recent Q1 losses, Nasdaq listing pressures, and an unused $50,000,000 shelf, investors may watch for concrete contracts or deployments that translate these public health concerns into measurable revenue. TOMI believes these converging public health threats are increasing institutional awareness of the importance of validated decontamination technologies such as SteraMist. In collaboration with the WHO and supported by a USAID 'Fighting Ebola: A Grand Challenge for Development' grant, TOMI deployed SteraMist to help contain the spread of the virus.

A university contract on May 14 and Q1 results plus a merger LOI on May 8 drew modest negative reactions. FREDERICK, Md., May 27, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. Teams utilized the system to secure high-risk "red zones" and safeguard healthcare personnel during the critical donning and doffing of protective gear.